Drug Database
Back to search

Poland· PL-100409743

Sunitynib Mylan

A sunitinib product containing sunitinibum, registered in Poland by Mylan Ireland Limited. The same ATC class is registered in 13 of our 19 countries.

ATC L01EX01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSunitynib MylanATCL01EX01REGISTER NO.PL-100409743PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sunitinibumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sunitinib is registered in 13 of 19 countries.

Countries holding a registration under ATC L01EX01 (sunitinib), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search sunitinib products by name

Sunitinib · ATC L01EX01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sunitinib costs, country by country.

Normalised to the WHO defined daily dose (33 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Sunitinib · price per daily dose (33 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$100.88
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Sunitinibum
Manufacturer
Mylan Ireland Limited
Country
Poland (PL)
ATC code
L01EX01
ATC class
Sunitinib
Defined daily dose
33 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909991419462
  • gtin
    05909991419479
  • gtin
    05909991419486
  • gtin
    05909991515041

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

464 interactions on record for sunitinib.

Graded by severity as the source publishes them — 99 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check sunitinib against other medicinesHow interaction checks work

Sunitinib · interactions on record

464 records

  • 99 severe
  • 362 moderate
  • 3 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sunitinib in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sunitinib products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Sunitinib Bluefish, Sunitinib G.L.
  • Belgium · Sunitinib Sandoz, Sunitinib Teva
  • Bulgaria · Суганет, Сунитиниб Алкалоид-Инт
  • Cyprus · Sunitinib Msn, Sunitinib Sapiens
  • Czechia · Sunitinib Pharmagen, Sunitinib Sandoz
  • Germany · Sunitinib Al, Sunitinib Aqvida
  • Denmark · Sunitinib Medical Valley, Sunitinib Sandoz
  • Estonia · Sunitinib Sandoz, Sunitinib Teva
  • Spain · Sunitinib Bluepharma Indústria, Sunitinib Dr. Reddys
  • Finland · Sunitinib Ratiopharm, Sunitinib Sandoz
  • France · Sunitinib Arrow, Sunitinib Biogaran
  • United Kingdom (Northern Ireland) · Sunitinib Amarox, Sunitinib Dr. Reddy’s
  • Greece · Egotux, Sunidem
  • Croatia · Sunitinib Alkaloid-Int, Sunitinib Be Pharma
  • Hungary · Klertis, Suganet
  • Ireland · Sunitinib Bluefish, Sunitinib Rowex
  • Iceland · Sunitinib Accord, Sunitinib Demo
  • Italy · Sunitinib Aurobindo, Sunitinib Dr. Reddy’s
  • Liechtenstein · Sunitinib Accord, Sutent
  • Lithuania · Klertis, Sunitinib G.L. Pharma
  • Luxembourg · Sunitinib Eg, Sunitinib Teva
  • Latvia · Sunitinib Be Pharma, Sunitinib G.L. Pharma
  • Malta · Sunitinib Dr. Reddy’s, Sunitinib Medichem
  • Netherlands · Egotux, Klertis
  • Norway · Sunitinib Accord, Sunitinib Medical Valley
  • Portugal · Sunitinib Bluepharma, Sunitinib Bluepharma Indústria
  • Romania · Klertis, Sunitinib Alkaloid-Int
  • Sweden · Sunitinib Bluefish, Sunitinib Eugia
  • Slovenia · Sunitinib Alkaloid-Int, Sunitinib Msn
  • Slovakia · Klertis, Sunitinib G.L. Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e59b7eee-9206-416e-a73f-108abde76d24
GET /v1/drugs/e59b7eee-9206-416e-a73f-108abde76d24?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "50 mg",
  "packaging": "05909991419462 ¦ Rpz ¦ 134789\n28 kaps. w blistrze perforowanym\n05909991419479 ¦ Rpz ¦ 134790\n28 kaps. w blistrze\n05909991419486 ¦ Rpz ¦ 134791\n30 kaps.\n05909991515041 ¦ Rpz ¦ 150161\n30 kaps. w blistrze perforowanym",
  "substance": "Sunitinibum 50 mg",
  "common_name": "Sunitinibum",
  "pl_product_id": "100409743",
  "pozwolenie_nr": "25672",
  "auth_procedure": "DCP",
  "authorisation_validity": "2025-07-14"
}
API referenceMCP serverPlans

See everything about sunitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console